3-(sec-Butylamino)tetrahydrothiophene 1,1-dioxide

Catalog No. :
ACCXMJ921
CAS No. :
4950-46-3
Molecular Formula :
C8H17NO2S
Molecular Weight :
191.30

IUPAC Name:3-(sec-butylamino)tetrahydrothiophene 1,1-dioxide

3-(sec-Butylamino)tetrahydrothiophene 1,1-dioxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$88.00Login to see priceInquiryInquiry
250mg97%$118.00Login to see priceInquiryInquiry
1g97%$298.00Login to see priceInquiryInquiry
5g97%$911.00Login to see priceInquiryInquiry
10g97%$1351.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(sec-Butylamino)tetrahydrothiophene 1,1-dioxide
IUPAC Name3-(sec-butylamino)tetrahydrothiophene 1,1-dioxide
MDL No.MFCD05688834
Molecular FormulaC8H17NO2S
Molecular Weight191.30
SMILESCCC(NC(CC1)CS1(=O)=O)C
InChI KeyIYMHRCANDIVXEC-UHFFFAOYSA-N
Synonym3-(Sec-Butylamino)tetrahydrothiophene 1,1-dioxide;3-Thiophenamine, tetrahydro-N-(1-methylpropyl)-, 1,1-dioxide
CAS No.4950-46-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCXMJ921 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYWFA378 route compound structure diagram
    ACYWFA37851642-03-6 In Stock
  4. Then
  5. ACCXMJ921 route product structure diagram
    ACCXMJ9214950-46-3
Inquiry

2. ACCXMJ921 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQWAT564 route compound structure diagram
    ACQWAT56417115-51-4 In Stock
  4. Then
  5. ACCXMJ921 route product structure diagram
    ACCXMJ9214950-46-3
Inquiry

Comments (0)